Angiodynamics Inc. (ANGO)
NASDAQ · Healthcare
Angiodynamics Inc. Shareholder Equity 2010–2025
Angiodynamics Inc. annual shareholder equity history from 2011 to 2025. Shareholder equity represents the net worth of a company, calculated as total assets minus total liabilities.
- Angiodynamics Inc. shareholder equity as of May 31, 2025: 183.0M, a 11.00% decrease year-over-year.
- Angiodynamics Inc. shareholder equity for 2025 were 183.0M, a 11.00% decrease from 2024.
- Angiodynamics Inc. shareholder equity for 2024 were 205.6M, a 45.65% decrease from 2023.
- Angiodynamics Inc. shareholder equity for 2023 were 378.3M, a 10.88% decrease from 2022.
- Angiodynamics Inc. shareholder equity for 2022 were 424.5M.
Shareholder Equity
ANNUAL · $B
YEAR-OVER-YEAR GROWTH · %
| Angiodynamics Inc. Annual Shareholder Equity (Millions of US $) | |
|---|---|
| 2025 | $183 |
| 2024 | $206 |
| 2023 | $378 |
| 2022 | $424 |
| 2021 | $439 |
| 2020 | $455 |
| 2019 | $615 |
| 2018 | $543 |
| 2017 | $515 |
| 2016 | $507 |
| 2015 | $545 |
| 2014 | $537 |
| 2013 | $526 |
| 2012 | $523 |
| 2011 | $406 |
Angiodynamics Inc. Shareholder Equity — FAQ
Angiodynamics Inc. (ANGO) shareholder equity over the last 16 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see ANGO's shareholder equity history?
The chart and table above show Angiodynamics Inc.'s shareholder equity by year and by quarter, including the growth rate.